Iovance Biotherapeutics
IOVA
IOVA
232 hedge funds and large institutions have $4.22B invested in Iovance Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 101 increasing their positions, 56 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 250 → 232 (-18)
15% less capital invested
Capital invested by funds: $4.98B → $4.22B (-$765M)
27% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 62
Holders
232
Holding in Top 10
7
Calls
$77.1M
Puts
$36.5M
Top Buyers
| 1 | +$87.7M | |
| 2 | +$63.4M | |
| 3 | +$61.1M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$60.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$44.4M |
Top Sellers
| 1 | -$115M | |
| 2 | -$59M | |
| 3 | -$57.4M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$55.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$46.4M |